VIATRIS INC. Operating Cash Flow
VIATRIS INC. (VTRS) reported Operating Cash Flow of $770.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- VIATRIS INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $381.80M, a 73.78% increase year-over-year.
- VIATRIS INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $388.30M, a 27.49% decline year-over-year.
- VIATRIS INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $815.80M, a 69.01% increase year-over-year.
- VIATRIS INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $744.90M, a 9.87% decline year-over-year.
- VIATRIS INC. net cash provided by (used in) operating activities for fiscal 2025 was $2.32B, a 0.56% increase from fiscal 2024.
- VIATRIS INC. net cash provided by (used in) operating activities for fiscal 2024 was $2.30B, a 20.59% decline from fiscal 2023.
- VIATRIS INC. net cash provided by (used in) operating activities for fiscal 2023 was $2.90B, a 3.30% decline from fiscal 2022.
- VIATRIS INC. net cash provided by (used in) operating activities for fiscal 2022 was $3.00B, a 0.59% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $381.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $770.10M 10-Q · filed 2026-08-06 | $1.59B derived: sum of 3 quarters · filed 2026-08-06 | $2.33B derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2026-03-31 | $388.30M 10-Q · filed 2026-05-07 | $1.20B derived: sum of 2 quarters · filed 2026-05-07 | $1.95B derived: sum of 3 quarters · filed 2026-05-07 | $2.17B derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-12-31 | $815.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.56B derived: sum of 2 quarters · filed 2026-02-26 | $1.78B derived: sum of 3 quarters · filed 2026-08-06 | $2.32B 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | $744.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $964.60M derived: sum of 2 quarters · filed 2026-08-06 | $1.50B 10-Q · filed 2025-11-06 | $1.98B derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-06-30 | $219.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $755.20M 10-Q · filed 2026-08-06 | $1.24B derived: sum of 3 quarters · filed 2026-08-06 | $2.06B derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-03-31 | $535.50M 10-Q · filed 2026-05-07 | $1.02B derived: sum of 2 quarters · filed 2026-05-07 | $1.84B derived: sum of 3 quarters · filed 2026-05-07 | $2.22B derived: sum of 4 quarters · filed 2026-05-07 | |||||||
| 2024-12-31 | $482.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.31B derived: sum of 2 quarters · filed 2026-02-26 | $1.69B derived: sum of 3 quarters · filed 2026-02-26 | $2.30B 10-K · filed 2026-02-26 | |||||||
| 2024-09-30 | $826.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.21B derived: sum of 2 quarters · filed 2025-11-06 | $1.82B 10-Q · filed 2025-11-06 | $2.39B derived: sum of 4 quarters · filed 2026-02-26 | |||||||
| 2024-06-30 | $379.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $993.70M 10-Q · filed 2025-08-07 | $1.56B derived: sum of 3 quarters · filed 2026-02-26 | $2.40B derived: sum of 4 quarters · filed 2026-02-26 | |||||||
| 2024-03-31 | $614.60M 10-Q · filed 2025-05-08 | $1.18B derived: sum of 2 quarters · filed 2026-02-26 | $2.02B derived: sum of 3 quarters · filed 2026-02-26 | $2.54B derived: sum of 4 quarters · filed 2026-02-26 | |||||||
| 2023-12-31 | $568.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.40B derived: sum of 2 quarters · filed 2026-02-26 | $1.93B derived: sum of 3 quarters · filed 2026-02-26 | $2.90B 10-K · filed 2026-02-26 | $2.80B 10-K · filed 2024-02-28 | ||||||
| 2023-09-30 | $835.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.36B derived: sum of 2 quarters · filed 2024-11-07 | $2.33B 10-Q · filed 2024-11-07 | $2.32B 10-Q · filed 2023-11-08 | $2.52B derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-06-30 | $525.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.50B 10-Q · filed 2024-08-08 | $1.49B 10-Q · filed 2023-08-07 | $1.69B derived: sum of 3 quarters · filed 2025-02-27 | $2.55B derived: sum of 4 quarters · filed 2025-02-27 | ||||||
| 2023-03-31 | $971.20M 10-Q · filed 2024-05-09 | $1.16B derived: sum of 2 quarters · filed 2025-02-27 | $2.03B derived: sum of 3 quarters · filed 2025-02-27 | $2.83B derived: sum of 4 quarters · filed 2025-02-27 | |||||||
| 2022-12-31 | $189.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.06B derived: sum of 2 quarters · filed 2025-02-27 | $1.86B derived: sum of 3 quarters · filed 2025-02-27 | $3.00B 10-K · filed 2025-02-27 | $2.95B 10-K · filed 2023-02-27 | ||||||
| 2022-09-30 | $869.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.67B derived: sum of 2 quarters · filed 2023-11-08 | $2.81B 10-Q · filed 2023-11-08 | $3.33B derived: sum of 4 quarters · filed 2024-02-28 | |||||||
| 2022-06-30 | $802.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.94B 10-Q · filed 2023-08-07 | $2.46B derived: sum of 3 quarters · filed 2024-02-28 | $3.55B derived: sum of 4 quarters · filed 2024-02-28 | |||||||
| 2022-03-31 | $1.14B 10-Q · filed 2023-05-08 | $1.66B derived: sum of 2 quarters · filed 2024-02-28 | $2.75B derived: sum of 3 quarters · filed 2024-02-28 | $3.31B derived: sum of 4 quarters · filed 2024-02-28 | |||||||
| 2021-12-31 | $523.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.61B derived: sum of 2 quarters · filed 2024-02-28 | $2.17B derived: sum of 3 quarters · filed 2024-02-28 | $3.02B 10-K · filed 2024-02-28 | |||||||
| 2021-09-30 | $1.09B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.65B derived: sum of 2 quarters · filed 2022-11-07 | $2.49B 10-Q · filed 2022-11-07 | $2.53B derived: sum of 4 quarters · filed 2023-02-27 | |||||||
| 2021-06-30 | $559.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.41B 10-Q · filed 2022-08-08 | $1.44B derived: sum of 3 quarters · filed 2023-02-27 | $1.97B derived: sum of 4 quarters · filed 2023-02-27 | |||||||
| 2021-03-31 | $848.80M 10-Q · filed 2022-05-09 | $885.00M derived: sum of 2 quarters · filed 2023-02-27 | $1.41B derived: sum of 3 quarters · filed 2023-02-27 | ||||||||
| 2020-12-31 | $36.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $561.20M derived: sum of 2 quarters · filed 2023-02-27 | $1.23B 10-K · filed 2023-02-27 | ||||||||
| 2020-09-30 | $525.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.20B 10-Q · filed 2021-11-08 | |||||||||
| 2020-09-27 | -$669.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$290.10M derived: sum of 2 quarters · filed 2021-08-09 | $1.00M 10-Q · filed 2020-11-10 | ||||||||
| 2020-06-30 | $379.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $670.60M 10-Q · filed 2021-08-09 | |||||||||
| 2020-06-28 | -$291.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | |||||||||
| 2020-03-31 | $291.10M 10-Q · filed 2021-05-10 | ||||||||||
| 2020-03-29 | $0.00 10-Q · filed 2020-05-12 | ||||||||||
| 2019-12-31 | $0.00 10-K · filed 2020-05-07 | $1.80B 10-K · filed 2022-02-28 | |||||||||
| 2019-09-29 | $0.00 10-Q · filed 2020-11-10 | ||||||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | ||||||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | ||||||||||
| 2018-12-31 | $2.34B 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |